BOEY DIN 02569086
Health Canada record
| Active ingredient(s) | TRENIBOTULINUMTOXINE 1400 UNIT |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intramuscular |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | M03AX01 BOTULINUM TOXIN |
| Original market date | |
| Current status date | 22-Jun-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37735 | 2026-06-22 | New Drug Submission (NDS) |